Colgate-Palmolive Company (CL)

Colgate-Palmolive Co. stock has experienced a decline of 3.82% over the past year. In Q4 2025, the company reported a GAAP net loss, but generated significant revenue and free cash flow for the full fiscal year. Q1 2026 saw sales growth, but EPS declined. The company announced an acceleration of a multi-year Strategic Growth and Productivity Program. Analyst sentiment for CL is generally a "Moderate Buy," with an average 12-month price target of approximately $95.56. Insider selling has also been noted.

Colgate-Palmolive's products generally experience steady demand due to being essential household staples. The company has benefited from this consistent demand, even amidst price increases, suggesting a relatively stable demand profile throughout the year.

Colgate-Palmolive is a global consumer products company specializing in oral care, personal care, home care, and pet nutrition. The company manufactures, markets, and distributes everyday consumer packaged goods through its Oral, Personal and Home Care, and Pet Nutrition divisions. Major products include toothpastes, toothbrushes, mouthwashes, soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and specialized pet food products.

Colgate-Palmolive has an extensive global presence, operating in over 200 countries and territories with 362 subsidiaries across 61 countries. The company has a significant concentration in the United States, France, and Italy, with a strong business network across North America and Europe. Colgate-Palmolive holds a superior geographic footprint in high-growth emerging markets, commanding over 40% of the global toothpaste market, and approximately two-thirds of its revenue is generated from markets outside North America.

Colgate-Palmolive has a strong brand reputation built on a long-standing legacy of providing trusted products and community outreach programs. The company has faced legal challenges and criticism from animal-rights groups in the past, but has taken steps to address these issues. The company's reputation has been generally associated with its defensive business model and reliable cash flows, and its ability to maintain strong market positions across its core categories.

Colgate-Palmolive's ownership is predominantly institutional, with institutional investors holding approximately 86% of the company's shares. Major institutional owners include The Vanguard Group, Inc., BlackRock, Inc., and State Street Global Advisors, Inc. Insider ownership is minimal, representing less than 1% of the total shares.